|
|
 |
|
|
| |
1970: Only
treatment for liver disease: prednisone
2006: Hepatitis A avoidable, hepatitis B avoidable and treatable,
hepatitis C discovered and treatable, hemochromatosis can be diagnosed
by molecular genetics. Liver transplantation has become a routine
surgical procedure.
Such progress in 35 years can be achieved only by research.
Medical research is done on three levels - all represented in our
institute:
- Basic research
- Translational research
- Clinical research
The institute of clinical pharmacology in Berne has always made major
contributions and given impulses to hepatology worldwide. A look back
in time::
Prof. R. Preisig, who was the founder and first director of the
institute, was world-wide renownded for his research in biliary
physiology and hemodynamics in liver disease. He was also a co-founder
of EASL, the European society devoted to Hepatology.
Prof. J. Bircher introduced the first (and still used) treatment of
hepatic encephalopathy with lactulose and laid the intellectual
foundation for the first effective treatment of E. multilocularis.
Prof. G. Paumgartner has introduced lithotripsy as a non-operative
method for the treatment of gallstones (as head of internal medicine in
Munich) . In Bern and Munich he made major contributions to our
understanding of biliary physiology, the associated transport processes
and their disturbance in cholestasis.
What their successors do, can be learnt by clicking
through the pull-down menus under research.
|
|
|
|
|
|
|
|
Stiftung
für
Leberkrankheiten
Institut für Klinische Pharmakologie
Universität Bern
Murtenstrasse 35,
Postfach 49
3010 Bern
0041 (0)31 632 31 91
Info@leberstiftung.ch |
|
|
